(Press-News.org) Fairfax, Va., October 9, 2013—Standard and reduced high-dose volume radiation therapy for muscle-invasive bladder cancer provide comparable tumor control and decreased late toxicity when compared to surgery, according to a study published in the October 1, 2013 print edition of the International Journal of Radiation Oncology ● Biology ● Physics, the official scientific journal of the American Society for Radiation Oncology (ASTRO). The research is part of the United Kingdom's BC2001 clinical trial, one of the largest randomized trials conducted involving radiation therapy (RT) in patients with muscle-invasive bladder cancer.
Cystectomy (partial or whole bladder removal surgery) is often the standard treatment for patients with muscle-invasive bladder cancer; however, advanced RT techniques that spare the bladder may be an effective alternative for patients who are unsuitable for or unwilling to undergo cystectomy. This research was conducted to determine if some of the drawbacks of RT of the bladder, such as local recurrence and late toxicity risks, could be reduced with a lower dose of RT being delivered to the areas of the bladder outside of the tumor region, and to assess the tumor control and toxicity of RT.
This phase III randomized trial was sponsored by the University of Birmingham, UK, supported by Cancer Research UK, and facilitated by the National Institute for Health Research Cancer Research Network. The cohort of participants for this portion of the trial included 219 patients from 28 centers across the United Kingdom who received either standard radiation therapy or reduced high-volume radiation therapy. Patients were all age 18 and older and had stage T2 – T4a bladder cancer. Study participants were randomized—108 received standard whole bladder radiation therapy (sRT) and the remaining 111 patients received reduced high-dose volume radiation therapy (RHDVRT), in which the full radiation dose was delivered to the tumor and 80 percent of the maximum dose was delivered to the uninvolved bladder. [360 patients in the BC2001 trial were also randomly assigned to receive radiation therapy alone or radiation therapy plus chemotherapy in a partial 2 x 2 factorial design; the results of the chemoradiation portion of the trial are not included in this manuscript.]
Study participants received RT doses based on their cancer center's choice of either 55 Gy/20 fractions over 4 weeks or 64 Gy/32 fractions over 6.5 weeks. For patients in the sRT group, the planning target volume (PTV) was the outer bladder wall, plus the extravesical extent of the tumor with a 1.5 cm margin. For patients in the RHDVRT group, two PTVs were defined: PTV1, as in the sRT group, and PTV2, as the gross tumor volume plus a 1.5 cm margin.
Patients were assessed weekly throughout treatment for toxicity; and side effects were measured at six, nine and 12 months post-treatment, and annually thereafter. Additionally, tumor control was assessed at six, nine and 12 months after treatment and then annually for up to five years. The median patient follow-up time was 72.7 months post-treatment.
In this radiation therapy volume comparison of the study, the primary endpoints of interest were late toxicity and local control. Late toxicity was determined in this study to be radiation therapy-related side effects at least one to two years post-treatment. The Radiation Therapy Oncology Group (RTOG) scale and Late Effects of Normal Tissue (Subjective, Objective, Management) (LENT/SOM) scale were utilized to measure late toxicity in study participants. Rates of late toxicity were lower than anticipated, and the number of patients reporting RTOG or LENT/SOM toxicities (side effects) was not significantly different between the sRT and RHDVRT groups. The overall cumulative Grades 3/4 RTOG toxicity rate was 13 percent at two years post-treatment, and the percentage of patients with Grades 3/4 toxicity at any specific point was shown to be < 8 percent throughout in both groups.
Two-year locoregional recurrence free (LRRF) rate was 61 percent for the sRT group and 64 percent for the RHDVRT group, but non-inferiority of locoregional control (proof that the RHDVRT treatment was at least not appreciably inferior than the sRT treatment) could not be formally determined in the study.
"We have now demonstrated that delivering at least 75 percent of the dose [of RT] to the uninvolved bladder is deliverable across multiple sites without obvious detriment to local disease control or survival, although non-inferiority could not be formally confirmed," said lead author Robert A. Huddart, PhD, of The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust. "These results confirm, however, that RT is an effective alternative for patients unable to undergo cystectomy. Further study using image-guided treatment with or without dose escalation is now also warranted."
INFORMATION:
For questions regarding the manuscript of the study or to arrange an interview with Dr. Huddart, contact Michelle Kirkwood at 703-286-1600, press@astro.org. For more information about the Red Journal, visit http://www.redjournal.org.
ABOUT ASTRO
ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other health care professionals that specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, the Society is dedicated to improving patient care through professional education and training, support for clinical practice and health policy standards, advancement of science and research, and advocacy. ASTRO publishes two medical journals, International Journal of Radiation Oncology • Biology • Physics and Practical Radiation Oncology; developed and maintains an extensive patient website, http://www.rtanswers.org; and created the Radiation Oncology Institute, a non-profit foundation to support research and education efforts around the world that enhance and confirm the critical role of radiation therapy in improving cancer treatment. To learn more about ASTRO, visit http://www.astro.org.
END
Researchers know that feeding some patients intravenously can save their lives – but also can cause liver damage. Now scientists at the University of Colorado and Children's Hospital Colorado have figured out the likely culprit, one of the ingredients in intravenous food, behind the liver problems.
The discovery, published Oct. 9 in Science Translational Medicine, could point the way to better treatments for patients who are medically vulnerable and, often, very young.
"We still have more to learn about the optimal mix of lipids for intravenous nutrition," said Ron ...
Terahertz (THz) radiation — radiation in the wavelength range of 30 to 300 microns — is gaining attention due to its applications in security screening, medical and industrial imaging, agricultural inspection, astronomical research, and other areas. Traditional methods of generating terahertz radiation, however, usually involve large and expensive instruments, some of which also require cryogenic cooling. A compact terahertz source — similar to the laser diode found in a DVD player —operating at room temperature with high power has been a dream device in the terahertz community ...
HOUSTON – (Oct. 9, 2013) – Carbyne will be the strongest of a new class of microscopic materials if and when anyone can make it in bulk.
If they do, they'll find carbyne nanorods or nanoropes have a host of remarkable and useful properties, as described in a new paper by Rice University theoretical physicist Boris Yakobson and his group. The paper appears this week in the American Chemical Society journal ACS Nano.
Carbyne is a chain of carbon atoms held together by either double or alternating single and triple atomic bonds. That makes it a true one-dimensional material, ...
New Rochelle, NY, October 9, 2013—A national survey has found that uterine fibroids have a disproportionate impact on African American women, causing more severe symptoms, interfering with their daily life, and causing them to miss work. These new findings are reported in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on the Journal of Women's Health website at http://www.liebertpub.com/jwh.
African American women have a 3-fold higher incidence of uterine fibroids and tend to have them at an ...
A new meta-analysis published today in the Journal of Alternative and Complementary Medicine (2013;19(10):1-12)1 found the Transcendental Meditation® technique (TM) has a large effect on reducing trait anxiety for people with high anxiety. Trait anxiety is a measure of how anxious a person usually is, as opposed to state anxiety, which refers to how anxious we are at the moment. A meta-analysis is an objective means to draw conclusions from all the research in a field.
This meta-analysis covered 16 randomized-controlled trials, the gold standard in medical research, and ...
More than 90 percent of the public supports organ donation, yet less than half the population registers as donors, surveys show.
What if registration was better promoted to those who had previously turned it down? And at the place almost everyone makes that decision, the DMV?
Research at 40 Department of Motor Vehicles facilities in Illinois shows such efforts can make a difference. An article about the work was published in the September/October issue of the journal Clinical Transplantation.
University of Illinois professor Brian Quick and his research colleagues implemented ...
Nyon, Switzerland (October 10, 2013) – According to a new report published today by the International Osteoporosis Foundation (IOF), women may expect to live longer but their quality of life will be seriously jeopardized if action to protect their bone health is not taken. Postmenopausal women are the most vulnerable to osteoporosis and fractures. Worldwide, an estimated 200 million women are affected by osteoporosis and around one in three women aged over 50 will suffer from a fracture due to the disease.
With an increasingly ageing population huge demands will be put ...
Vast areas on the Northern Hemisphere are covered by tundra. Here, dwarf shrubs, sedges, mosses etc. thrive on top of permafrost in areas where only the uppermost soil layer thaws during the short Arctic summer.
New studies show that the tundra may become a source of CO2 in the future. Researcher Magnus Lund from Aarhus University explains:
"The soil below the tundra contains very large quantities of carbon – more than twice as much as is present in the planet's entire atmosphere. Therefore, we would like to know if the carbon will stay put – or if it will be released ...
To most people, restoration of Florida's Everglades means recovering and protecting the wetlands of south Florida, including Everglades National Park. But what many don't realize is how intimately the fortunes of the southern Everglades are tied to central Florida's Lake Okeechobee and lands even further north.
"The Everglades at the southern tip of Florida—the remains of what was once a vast ecosystem—is interconnected with a large hydrologic system that really begins in Orlando with the northern Everglades," says Patrick Bohlen, a professor of biology at University ...
(CHICAGO) –Although problems with memory become increasingly common as people age, in some persons, memories last long time, even a life time. On the other hand, some people experience milder to substantial memory problems even at an earlier age.
Although there are several risk factors of dementia, abnormal fat metabolism has been known to pose a risk for memory and learning. People with high amounts of abdominal fat in their middle age are 3.6 times as likely to develop memory loss and dementia later in their life.
Neurological scientists at the Rush University Medical ...
